Swiss National Bank Has $99.12 Million Position in GE HealthCare Technologies Inc. $GEHC

Swiss National Bank cut its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,319,887 shares of the company’s stock after selling 66,100 shares during the quarter. Swiss National Bank’s holdings in GE HealthCare Technologies were worth $99,124,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Dodge & Cox lifted its holdings in shares of GE HealthCare Technologies by 42.1% during the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after buying an additional 6,982,441 shares in the last quarter. Norges Bank acquired a new stake in GE HealthCare Technologies in the 2nd quarter worth about $468,120,000. Holocene Advisors LP boosted its holdings in GE HealthCare Technologies by 178.5% in the 2nd quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after purchasing an additional 2,581,522 shares during the period. Menora Mivtachim Holdings LTD. acquired a new position in shares of GE HealthCare Technologies during the 2nd quarter worth approximately $80,755,000. Finally, Balyasny Asset Management L.P. bought a new position in shares of GE HealthCare Technologies during the second quarter worth approximately $58,388,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $72.73 on Wednesday. The business has a fifty day simple moving average of $81.44 and a 200 day simple moving average of $78.61. The company has a market cap of $33.15 billion, a P/E ratio of 15.95, a P/E/G ratio of 1.66 and a beta of 1.03. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter in the previous year, the firm earned $1.45 earnings per share. The business’s quarterly revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is presently 3.07%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on GEHC shares. Stifel Nicolaus increased their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Jefferies Financial Group increased their target price on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Citigroup upped their price objective on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Bank of America increased their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th. Finally, Piper Sandler boosted their target price on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research report on Friday, January 30th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $92.50.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.